-
Sleep-deprived individuals appear less healthy, tired, and less attractive to untrained observers than when they are rested.
-
The most recent ada/easd algorithm for management of type 2 diabetes (DM2) indicates basal insulin as an appropriate next step if glycemic goals are not attained with metformin and lifestyle interventions.
-
A new chemotherapeutic agent has been approved for the treatment of metastatic breast cancer previously treated with other chemotherapeutic agents.
-
Simply increasing the number of steps taken daily reduces obesity and improves insulin sensitivity in middle-aged adults.
-
Although most older women have stable patterns of alcohol use over time, they still need to be periodically questioned about alcohol use since some will increase their intake substantially after age 50, and may develop new risks for alcohol-related problems.
-
It seems reasonable to assume that atorva-statin has some anti-ischemic properties, based on the strong correlation between subjective angina reduction and reduction in objective ischemia demonstrated on AECG monitoring. However, there was no incremental benefit to the combination of atorvastatin and amlodipine.
-
Clinicians should consider prescribing levothyroxine at bedtime since this study demonstrates significantly improved thyroid hormone levels compared to morning intake.
-
Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions.
-
Immunochemical fecal occult blood testing (i-FOBT) is becoming increasingly popular as a screening tool for colorectal cancer (CRC).
-
Easily obtained clinical variables can identify patients at very low risk for subarachnoid hemorrhage.